En Es
Categories

iCAD

iCAD

Offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers
Products NewsSummary
Close

News of iCAD

Solución de IA gana el premio a mejor solución nueva de radiología

25 Sep 2019
Solución de IA gana el premio a mejor solución nueva de radiología
Una solución de inteligencia artificial (IA) aprobada por la FDA que permite la detección del cáncer de mama en la tomosíntesis digital de mama (TDM) 3D fue seleccionada como la ganadora del Premio a la “Mejor Nueva Solución de Radiología” en el programa de Premios MedTech Breakthrough Awards de 2019.
Read More

AI Solution Supporting Wins Best New Radiology Solution Award

18 Sep 2019
AI Solution Supporting Wins Best New Radiology Solution Award
An FDA-cleared artificial intelligence (AI) solution that supports breast cancer detection in 3D tomosynthesis has been selected as the winner of “Best New Radiology Solution” Award in the 2019 MedTech Breakthrough Awards program.
Read More

Tecnología de IA para la detección del cáncer de mama recibe la aprobación de la Marca CE

25 Jul 2019
Tecnología de IA para la detección del cáncer de mama recibe la aprobación de la Marca CE
iCAD, Inc. (Nashua, NH, EUA), un proveedor de soluciones de terapia y detección de cáncer, ha recibido la aprobación de la Marca CE para su solución de flujo de trabajo y tecnología de inteligencia artificial (IA), AI ProFound, para mamografías en 2D. La tecnología es la última incorporación a la plataforma ProFound IA de aprendizaje profundo de iCAD, que se une a ProFound IA para la Tomosíntesis Digital de Seno (DBT, por sus siglas en inglés), que obtuvo la marca CE en marzo de 2018, fue aprobada por la FDA en diciembre de 2018 y Health Canadá la licenció en julio de 2018. La tecnología se desarrolló para apoyar la detección del cáncer de mama, mediante la identificación de las densidades de los tejidos blandos y las calcificaciones. 
Read More

Una tecnología para la detección del cáncer basada en la IA recibe aprobación de la FDA

02 Jan 2019
Una tecnología para la detección del cáncer basada en la IA recibe aprobación de la FDA
 Una solución nueva de software para la detección de cáncer que usa aprendizaje profundo para la tomosíntesis digital de seno (DBT, por sus siglas en inglés) ha recibido la aprobación de la FDA de los EUA para ventas comerciales y uso clínico en los EUA. La solución denominada ProFound AI se basa en inteligencia artificial (IA) y ha sido desarrollada por iCAD, Inc. (Nashua, NH, EUA), un proveedor de soluciones de terapia y detección para el cáncer.

Read More

Cancer Detection Technology Built on AI Receives FDA Clearance

25 Dec 2018
Cancer Detection Technology Built on AI Receives FDA Clearance
A new deep-learning cancer detection software solution for digital breast tomosynthesis (DBT) has received clearance from the US FDA for commercial sales and clinical use in US. The solution named ProFound AI is built on artificial intelligence (AI) and has been developed by iCAD, Inc, a provider of cancer detection and therapy solutions.
Read More

Un estudio demuestra las ventajas de la IA para la tomosíntesis digital de mama

31 Oct 2018
Un estudio demuestra las ventajas de la IA para la tomosíntesis digital de mama
 Un estudio del software de detección de cáncer de tomosíntesis digital de mama (DBT, por sus siglas en inglés) realizado por iCAD, Inc. (Nashua, NH, EUA) ha demostrado mejoras sin precedentes en el desempeño clínico y los tiempos de lectura, lo que valida los beneficios sustanciales de la inteligencia artificial (IA) cuando se utiliza con la mamografía tridimensional (3D).
Read More

Study Demonstrates Advantages of AI for Digital Breast Tomosynthesis

25 Oct 2018
Study Demonstrates Advantages of AI for Digital Breast Tomosynthesis
A study of digital breast tomosynthesis (DBT) cancer detection software by iCAD, Inc. has demonstrated unprecedented improvements in clinical performance and reading times, validating the substantial benefits of Artificial Intelligence (AI) when used with three-dimensional (3D) mammography.
Read More
Close

About iCAD

Number of Employees: 100-499
Offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers

Recently updated

3D Mammography Software
ProFound AI

ProFound AI is a high-performance, deep-learning workflow solution for 2D mammography and digital breast tomosynthesis that is trained to detect malignant soft-tissue densities and calcifications. It is clinically proven to improve radiologists’ performance and diagnostic confidence, while offering critical time-saving benefits.
More details

Breast Cancer Detection Platform
PowerLook Mammo Detection

The PowerLook Mammo Detection is based on sophisticated patented algorithms that analyze the data, automatically identifying and marking suspicious regions in 2D mammography images. The solution provides the radiologist with a “second look” which helps the radiologist detect actionable missed cancers earlier than screening mammography alone.
More details

Auto Breast Density Solution
PowerLook Density Assessment

The PowerLook Density Assessment is an automated breast density solution that is designed to standardize the assessment and reporting of breast density. It assists radiologists in evaluating and scoring breast density to identify patients who may be at higher risk of developing breast cancer.
More details

Medical Imaging

3D Mammography Software
ProFound AI

ProFound AI is a high-performance, deep-learning workflow solution for 2D mammography and digital breast tomosynthesis that is trained to detect malignant soft-tissue densities and calcifications. It is clinically proven to improve radiologists’ performance and diagnostic confidence, while offering critical time-saving benefits.
More details

Breast Cancer Detection Platform
PowerLook Mammo Detection

The PowerLook Mammo Detection is based on sophisticated patented algorithms that analyze the data, automatically identifying and marking suspicious regions in 2D mammography images. The solution provides the radiologist with a “second look” which helps the radiologist detect actionable missed cancers earlier than screening mammography alone.
More details

Auto Breast Density Solution
PowerLook Density Assessment

The PowerLook Density Assessment is an automated breast density solution that is designed to standardize the assessment and reporting of breast density. It assists radiologists in evaluating and scoring breast density to identify patients who may be at higher risk of developing breast cancer.
More details

Radiologist Workflow Solution
PowerLook Tomo Detection

The PowerLook Tomo Detection is an innovative radiologist workflow solution built on the latest advances in pattern recognition for advanced cancer detection. It is designed to optimize breast tomosynthesis reading efficiency, streamline workflow, and support cancer detection without compromising reading performance or increasing recalls.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions